Latent Abnormal Pathology Affects Long-Term Graft Function in Elder Living Renal Allograft Recipients

Table 3

Comparisons between postoperative renal function in cases with or without pathological changes.

Group

Average age

SCr

BUN^&

UA^Δ

D

R

3**

6

12

24

3

6

12

24

3

6

12

24

Total

40±7

33±5

115±26

120±19

124±13

138.8±67

6.2±1.6

6.6±1.1

6.6±1.8

7±3.3

324±91

350±130

334±13

349±121

Normal

37±8

35±13

112±18

106±17

124.7±19.8

113±9.3

6.6±1.4

6.4±2.6

6.4±3

6.4±2.1

320±46

329±33

345±37

344±30

Change

44±12

30±10

111±23

110±19

109.6±18

154±140

7.1±3.4

6.9±1.9

6.7±2

7.9±3.6

336±99

343±87

42±91

365±98

Compared with and without pathological changes: *age of donor, 𝑃=0.02; ^#serum Cr (umol/L), 𝑃=0.550; ^&BUN (mmol/L), 𝑃=0.13; Δuric acid, 𝑃=0.11; **postoperative months; D: donor; R: recipient; UA: uric acid (mmol/L).